FDA Panel Recommends Approval for Novartis CAR T Cell Treatment in Leukemia
The Food and Drug Administration panel opened the door to widespread use of CAR T Cell therapy on Wednesday, unanimously…
Myeloma 101: What is a “Line” of Therapy in Multiple Myeloma?
Many myeloma clinical trials include approval criteria based on the number of “lines” of therapy a patient has already received.…
Our Next Show: ASCO and EHA Myeloma Meeting Updates with Sagar Lonial, MD, Winship Cancer Institute, Wednesday, July 19 @ 2 pm Eastern
Wednesday, July 19, 2017 @ 11 am Pacific, Noon Mountain, 1 pm Central, 2 pm Eastern Call In by Phone…
Full Show: New Bi-Specific Antibody Hitting Two Targets in Myeloma, Dirk Hose, MD and Anja Seckinger, MD, University of Heidelberg
Dirk Hose, MD Anja Seckinger, MD Interview Date: May 24, 2017 Summary Many myeloma patients are familiar with monoclonal antibodies,…
Our Next Show: ASCO and EHA Myeloma Meeting Updates with Sagar Lonial, MD, Winship Cancer Institute, Wednesday, July 19 @ 2 pm Eastern
Wednesday, July 19, 2017 @ 11 am Pacific, Noon Mountain, 1 pm Central, 2 pm Eastern Call In by Phone…
Clinical Trial: Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
Smoldering myeloma (SMM) is considered a precursor of multiple myeloma for a percentage of patients. The current standard of care…
UPCOMING MYELOMA CROWD ROUNDTABLES
September 30, 2017, Myeloma Crowd Round Tables: New York, NY
Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so…
August 19, 2017, Myeloma Crowd Round Tables: Jackson, Mississippi
Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so…
September 23, 2017, Myeloma Crowd Round Tables: Detroit, Michigan
Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so…
MYELOMA CROWD RESEARCH CAMPAIGNS
Myeloma Crowd Research Initiative (MCRI) Funds Two Immunotherapy Projects
The Myeloma Crowd Initiative selected two proposals it has selected for the MCRI crowdsourcing and…
Continuing the Fight for a Myeloma Cure: Dr. Tricot and Dr. Zhan’s Research to Improve Outcomes for High-Risk Myeloma Patients
Guido Tricot, MD, PhD has devotedly attended to thousands of multiple myeloma patients for over…
Thanks to our site sponsors:
